Arcutis Biotherapeutics Stock Options
| ARQT Stock | USD 14.71 0.09 0.62% |
Arcutis Biotherapeutics' latest option contracts expiring on January 17th 2025 are carrying combined implied volatility of 1.97. The Arcutis Biotherapeutics option chain provides detailed quote and price information for the current Arcutis Biotherapeutics option contracts. It shows all of Arcutis Biotherapeutics' listed puts, calls, expiration dates, strike prices, and other pricing information.
In The Money vs. Out of Money Option Contracts on Arcutis Biotherapeutics
Analyzing Arcutis Biotherapeutics' in-the-money options over time can help investors to take a profitable long position in Arcutis Biotherapeutics regardless of its overall volatility. This is especially true when Arcutis Biotherapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Arcutis Biotherapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Arcutis Biotherapeutics' stock while costing only a fraction of its price.
Arcutis Biotherapeutics In The Money Call Balance
When Arcutis Biotherapeutics' strike price is surpassing the current stock price, the option contract against Arcutis Biotherapeutics stock is said to be in the money. When it comes to buying Arcutis Biotherapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Arcutis Biotherapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Arcutis Current Options Market Mood
Arcutis Biotherapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Arcutis Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Unfortunately, most Arcutis Biotherapeutics' options investors are not very successful. Arcutis Biotherapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Arcutis contract
Base on the Rule 16, the options market is currently suggesting that Arcutis Biotherapeutics will have an average daily up or down price movement of about 0.12% per day over the life of the 2025-01-17 option contract. With Arcutis Biotherapeutics trading at USD 14.71, that is roughly USD 0.0181. If you think that the market is fully incorporating Arcutis Biotherapeutics' daily price movement you should consider buying Arcutis Biotherapeutics options at the current volatility level of 1.97%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Arcutis |
Purchasing Arcutis Biotherapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Arcutis calls. Remember, the seller must deliver Arcutis Biotherapeutics stock to the call owner when a call is exercised.
Arcutis Biotherapeutics Option Chain
When Arcutis Biotherapeutics' strike price is surpassing the current stock price, the option contract against Arcutis Biotherapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Arcutis Biotherapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Arcutis. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Arcutis. It also shows strike prices and maturity days for a Arcutis Biotherapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | ARQT250117C00002500 | 0 | 2.5 | 5.5 - 10.0 | 5.5 | In |
Call | ARQT250117C00005000 | 0 | 5.0 | 3.1 - 7.5 | 3.1 | In |
Call | ARQT250117C00007500 | 0 | 7.5 | 2.75 - 5.5 | 3.28 | In |
Call | ARQT250117C00010000 | 0 | 10.0 | 0.0 - 4.9 | 4.9 | |
Call | ARQT250117C00012500 | 0 | 12.5 | 0.0 - 4.9 | 4.9 | |
Call | ARQT250117C00015000 | 0 | 15.0 | 0.0 - 4.9 | 4.9 | |
Call | ARQT250117C00017500 | 0 | 17.5 | 0.0 - 5.0 | 5.0 | |
Call | ARQT250117C00020000 | 0 | 20.0 | 0.0 - 5.0 | 5.0 | |
Put | ARQT250117P00002500 | 0 | 2.5 | 0.0 - 5.0 | 5.0 | |
Put | ARQT250117P00005000 | 0 | 5.0 | 0.0 - 5.0 | 5.0 | |
Put | ARQT250117P00007500 | 0 | 7.5 | 0.0 - 4.9 | 4.9 | |
Put | ARQT250117P00010000 | 0 | 10.0 | 0.0 - 5.0 | 5.0 | In |
Put | ARQT250117P00012500 | 0 | 12.5 | 0.85 - 5.5 | 0.85 | In |
Put | ARQT250117P00015000 | 0 | 15.0 | 2.8 - 7.5 | 2.8 | In |
Put | ARQT250117P00017500 | 0 | 17.5 | 5.0 - 9.6 | 5.0 | In |
Put | ARQT250117P00020000 | 0 | 20.0 | 7.5 - 11.9 | 7.5 | In |
Arcutis Biotherapeutics Market Cap Over Time
Market Cap |
| Timeline |
Arcutis Total Stockholder Equity
Total Stockholder Equity |
|
Arcutis Biotherapeutics Corporate Management
| JD Esq | General VP | Profile | |
| Patricia Turney | VP Operations | Profile | |
| Todd Edwards | Executive Officer | Profile | |
| Eric McIntyre | Head Relations | Profile | |
| Ayisha Jeter | Head Access | Profile | |
| David Osborne | Chief Officer | Profile | |
| Bethany Dudek | Chief Officer | Profile |
Additional Tools for Arcutis Stock Analysis
When running Arcutis Biotherapeutics' price analysis, check to measure Arcutis Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcutis Biotherapeutics is operating at the current time. Most of Arcutis Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Arcutis Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcutis Biotherapeutics' price. Additionally, you may evaluate how the addition of Arcutis Biotherapeutics to your portfolios can decrease your overall portfolio volatility.